| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by investing activities | 287,108 | 191,553 |
| Net proceeds from stock option exercises and employee stock purchase plan | 6,119 | 1,684 |
| Net cash provided by financing activities | 6,119 | 1,684 |
| Net change in cash and cash equivalents | 16,463 | 4,624 |
| Cash and cash equivalents at beginning of period | 76,247 | - |
| Cash and cash equivalents at end of period | 92,710 | - |
AGIOS PHARMACEUTICALS, INC. (AGIO)
AGIOS PHARMACEUTICALS, INC. (AGIO)